Vitreous Tamponades Market Ongoing Research Report 2021-2028 | Alchimia srl, Alcon, Bausch Health Companies, Carl Zeiss Meditec AG

The most widely utilized tamponade agents are gases and silicone oil, which give a flawless tamponading action to the superior part of the retina. Since these agents are super lightweight, they have inadequate contact with the inferior retina.

Statistics
The global vitreous tamponades market is expected to be worth US$ 92.3 million by 2028.

Global Vitreous Tamponades Market: Drivers

The rising incidence of age-related macular degeneration (AMD) is expected to drive the global vitreous tamponades market growth during the forecast period. According to the Bright Focus Foundation, 11 million people in the U.S. have some type of age-related macular degeneration, and that figure is expected to double to around 22 million by 2050.

To Get more Business Statergies Request for Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/1193

Global Vitreous Tamponades Market: Opportunities

Research in vitreous tamponades is expected to provide attractive growth possibilities for global vitreous tamponades market players. For instance, the study 'Risk Factors for Retinal Redetachment After Silicone Oil Removal: A Systematic Review and Meta-Analysis' published in June 2018 found that ocular trauma, the scleral encircling band, lack of 360° laser, high myopia, aphakic eye, and previous failed retinal surgery, were all major risk factors for the incidence of retinal redetachment after silicone oil removal.

Global Vitreous Tamponades Market: Restraints

The decline in diabetic retinopathy incidences in North America is expected to propel the global vitreous tamponades market growth over the forecast period. For instance, the study, ‘Prevalence of diabetic retinopathy and diabetic macular edema in a primary care-based teleophthalmology program for American Indians and Alaskan Natives’ in June 2018 reported that the incidences of diabetic macular edema were less than that reported in Alaska Natives and non- American Indians. The incidences of diabetic retinopathy were around half that in previous reports for Alaska Natives and American Indians.

Key Takeaways:

The global vitreous tamponades market was worth US$ 76.0 Million in 2019 and is expected to be worth US$ 92.3 million by 2027, witnessing a CAGR of 2.4% during the forecast period 2020 – 2027. The rising incidence of age-related macular degeneration (AMD) is expected to drive the global vitreous tamponades market growth during the forecast period.

The gases vitreous tamponades segment accounted for the largest share in the global vitreous tamponades market in 2019, contributing to 81.3 % of the market share in terms of value; segment growth is due to increased R&D activities.

To Get Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/1193

Market Trends

Key players in the global vitreous tamponades market are focusing on several marketing tactics to increase their market share. For instance, during the European Society of Cataract and Refractive Surgery (ESCRS) Annual Meeting in Paris in September 2019, the ZEISS Medical Technology Segment of Carl Zeiss Meditec AG showcased innovative digital and market first solutions.
Key market players are concentrated on proving conformity with regulatory standards.

For instance, Alchimia Srl confirmed in July 2019 that the company's manufacturing location is U.S. food and drug administration approved
Global Vitreous Tamponades Market: Competitive Landscape

Some of the key players contributing to the global vitreous tamponades market are Dutch Ophthalmic Research Center (International) B.V., Carl Zeiss Meditec AG, Alcon, Inc., Alchimia Srl, Fluoron GmbH, Bausch Health Companies Inc., and Croma-Pharma GmbH.

Global Vitreous Tamponades Market: Key Developments

Major players in the global vitreous tamponade market are concentrating on public awareness campaigns. For instance, Bausch + Lomb partnered with Prevent Blindness, a volunteer eye health non-profit organization, for the fifth year in a row in February 2020 to promote awareness of Age-Related Macular Degeneration (AMD), one of the main causes of loss of vision in adults of age 50 and above.

Get Discount On The Purchase Of This Report @: https://www.coherentmarketinsights.com/promo/buynow/1193

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Coherent Market Insights :

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.